And the Nobel prize for vision award goes to?

Article

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

The $1.3 million award, the largest of its kind in ophthalmology will be shared between J Anthony Movshon, director of New York University’s Centre for Neural Science and William T. Newsome, a neuroscientist at Stanford University.

For over three decades both scientists have worked jointly and separately on the way our brains process visual information, supporting our perception. Leonor Beleza, president of The Champalimaud Foundation, said: “Visual perception starts with the eyes, but it happens in the brain. Over a 30-year period, the work of Movshon and Newsome has taken this axiom to new scientific levels of understanding. Because of these two outstanding neuroscientists, we now have a fundamental appreciation for the role of neurons in how we see things move about in the world. Their ground-breaking work, taken together and individually, has laid the basis for continued research on how the brain and its processes impact vision and perception. We are very proud to recognize Movshon and Newsome as the recipients of the 2010 Champalimaud Vision Award.”

According to www.healthnewsdigest.com William Newsome heard about the award following a weekly lab meeting when he listened to his mobile phone messages: “There was a message from my wife telling me an ophthalmologist in Portugal had called and told her he was absolutely sure I would really, really want to call him back.” The ophthalmologist turned out to be a member of the Champalimaud jury panel: Alfred Summer, MD, dean of the School of Hygiene and Public Health and professor of ophthalmology, epidemiology and international health at Johns Hopkins University.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.